Wear Behavior of Milled Posterior Crowns Fabricated From the New Monolithic Zirconia 5Y-TZP/3Y-TZP Compared to Lithium Disilicate
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04805281 |
|
Recruitment Status :
Recruiting
First Posted : March 18, 2021
Last Update Posted : June 10, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Posterior Teeth Worn Posterior Teeth Endodontically Treated Teeth Crowned Posterior Teeth | Other: monolithic zirconia (5Y-TZP/3-YTZ) ZirCAD Prime. Other: Lithium Dislicate IPS e.max crown | Not Applicable |
- There will be no difference in wear caused by monolithic Zirconia (5Y-TZP/3Y-TZP) IPS E-max ZirCad Prime and Lithium Disilicate IPS e.max CAD to the antagonist.
- There will be no difference in the wear of the new monolithic zirconia IPS e.max ZirCAD Prime and lithium disilicate IPS e.max CAD.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 24 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Other |
| Official Title: | Wear Behavior of Milled Posterior Crowns Fabricated From the New Gradient Technology Monolithic Zirconia 5Y-TZP/3Y-TZP Compared to Lithium Disilicate: (Randomized Clinical Trial) |
| Estimated Study Start Date : | August 1, 2021 |
| Estimated Primary Completion Date : | March 1, 2022 |
| Estimated Study Completion Date : | June 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
| Active Comparator: Lithium Disilicate IPS e.max crowns in posterior teeth |
Other: Lithium Dislicate IPS e.max crown
wear of lithium disilicate IPS e.max crown in posterior teeth |
| Experimental: Monolithic Zirconia (5Y-TZP/3-YTZP) crowns in posterior teeth |
Other: monolithic zirconia (5Y-TZP/3-YTZ) ZirCAD Prime.
wear of the new material of monolithic zirconia (5Y-TZP/3-YTZ) ZirCAD Prime in posterior teeth |
- The amount of occlusal wear in natural antagonist enamel caused by the restorative material [ Time Frame: 1 year ]The amount of occlusal wear in natural antagonist enamel, using digital superimposition of model scans after 1 year, measured in micrometer.
- The amount of occlusal wear in the restorative material itself [ Time Frame: 1 year ]The amount of occlusal wear in the restorative material itself, using digital superimposition of model scans after 1 year, measured in micrometers.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 21 Years to 50 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-
All subjects are required to:
1- Be aged 21-50 years old, be able to read and sign the informed consent document. 2- Psychologically and physically able to withstand conventional dental procedures.
3- Patients with mutilated posterior teeth indicated for full coverage restorations.
4- Patients with sound natural antagonists. 5- Able to attend punctually for preplanned visits and evaluation. 6- Have no active periodontal or pulpal diseases.
7- There should be no apparent loss or wear in opposing enamel.
Exclusion Criteria:
- Patient with active resistant periodontal diseases.
- Patients with parafunctional habits and bruxism.
- Patients with poor oral hygiene, high caries risk and uncooperative patients. 3- Pregnant women.
- Patients in the growth stage with partially erupted teeth. 5- Psychiatric problems or unrealistic expectations.
6- Lack of opposing dentition in the area of interest. 7- Restored occlusal surface opposing the planned restoration. 8- The presence of a removable or fixed orthodontic appliance.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04805281
| Contact: Noran El Sharkawi, MSc | 01006365953 ext 02 | noran.elsharqawy@dentistry.cu.edu.eg | |
| Contact: Rana Sherif, professor |
| Egypt | |
| Cairo University | Recruiting |
| Cairo, Egypt, 11865 | |
| Contact: Noran El Sharkawi, MSc of fixed prosthodontics 01006365953 ext 02 noran.elsharqawy@dentistry.edu.eg | |
| Contact: Rana Sherif | |
| Responsible Party: | Noran El-sharkawi, principal investigator, Cairo University |
| ClinicalTrials.gov Identifier: | NCT04805281 |
| Other Study ID Numbers: |
201020 |
| First Posted: | March 18, 2021 Key Record Dates |
| Last Update Posted: | June 10, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Tooth, Nonvital Dental Pulp Diseases Tooth Diseases Stomatognathic Diseases Lithium Carbonate Antidepressive Agents Psychotropic Drugs |
Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Antimanic Agents Tranquilizing Agents Central Nervous System Depressants Physiological Effects of Drugs |

